1 Sara M. Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA; Elisabeth De Kermadec, MD, MPH, Sanofi, Cambridge, MA; Patrick Cohen, MD, Sanofi, Vitry-sur-Seine, France; Gautier Paux, MSc, and Lei Wang, PhD, Sanofi, Cambridge, MA; and Seock-Ah Im, MD, PhD, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.